Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D

被引:134
作者
Krockenberger, Mathias [1 ,2 ]
Dombrowski, Yvonne [1 ,2 ]
Weidler, Claudia [1 ,2 ]
Ossadnik, Monika [1 ,2 ]
Hoenig, Arnd [1 ,2 ]
Haeusler, Sebastian [1 ]
Voigt, Heike [3 ]
Becker, Juergen C. [3 ]
Leng, Lin [5 ]
Steinle, Alexander [4 ]
Weller, Michael [7 ]
Bucala, Richard [5 ,6 ]
Dietl, Johannes [1 ]
Wischhusen, Joerg [1 ,2 ]
机构
[1] Univ Wurzburg, Dept Obstet & Gynecol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Interdisciplinary Ctr Clin Res, D-97080 Wurzburg, Germany
[3] Univ Wurzburg, Clin Res Grp KFO 124, D-97080 Wurzburg, Germany
[4] Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany
[5] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA
[6] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA
[7] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland
关键词
D O I
10.4049/jimmunol.180.11.7338
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The proinflammatory cytokine macrophage migration inhibitory factor (MIF) stimulates tumor cell proliferation, migration, and metastasis; promotes tumor angiogenesis; suppresses p53-mediated apoptosis; and inhibits antitumor immunity by largely unknown mechanisms. We here describe an overexpression of MIF in ovarian cancer that correlates with malignancy and the presence of ascites. Functionally, we find that MIF may contribute to the immune escape of ovarian carcinoma by transcriptionally down-regulating NKG2D in vitro and in vivo which impairs NK cell cytotoxicity toward tumor cells. Together with the additional tumorigenic properties of MIF, this finding provides a rationale for novel small-molecule inhibitors of MIF to be used for the treatment of MIF-secreting cancers.
引用
收藏
页码:7338 / 7348
页数:11
相关论文
共 54 条
[1]  
AGARWAL R, 2007, AM J OBSTET GYNECOL, V348, pE341
[2]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[3]  
Apte RS, 1998, J IMMUNOL, V160, P5693
[4]   Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancer [J].
Barber, Amorette ;
Zhang, Tong ;
Sentman, Charles L. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (01) :72-78
[5]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[6]   MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].
BERNHAGEN, J ;
CALANDRA, T ;
MITCHELL, RA ;
MARTIN, SB ;
TRACEY, KJ ;
VOELTER, W ;
MANOGUE, KR ;
CERAMI, A ;
BUCALA, R .
NATURE, 1993, 365 (6448) :756-759
[7]   PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) [J].
BERNHAGEN, J ;
MITCHELL, RA ;
CALANDRA, T ;
VOELTER, W ;
CERAMI, A ;
BUCALA, R .
BIOCHEMISTRY, 1994, 33 (47) :14144-14155
[8]   MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment [J].
Bernhagen, Juergen ;
Krohn, Regina ;
Lue, Hongqi ;
Gregory, Julia L. ;
Zernecke, Alma ;
Koenen, Rory R. ;
Dewor, Manfred ;
Georgiev, Ivan ;
Schober, Andreas ;
Leng, Lin ;
Kooistra, Teake ;
Fingerle-Rowson, Guenter ;
Ghezzi, Pietro ;
Kleemann, Robert ;
McColl, Shaun R. ;
Bucala, Richard ;
Hickey, Michael J. ;
Weber, Christian .
NATURE MEDICINE, 2007, 13 (05) :587-596
[9]   MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].
BLOOM, BR ;
BENNETT, B .
SCIENCE, 1966, 153 (3731) :80-&
[10]   Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis [J].
Bozza, M ;
Satoskar, AR ;
Lin, GS ;
Lu, B ;
Humbles, AA ;
Gerard, C ;
David, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :341-346